Skip to content
OpenCapital
Get started

NeoGenomics NEO Reportable Segment — Amortization

Similar metrics at other companies

VGN
VGNTReportable Segment — Amortization
$1M—
Concentrix Corporation logo
CNXCReportable Segment — Amortization
$103.46M-2.0%
Waystar Holding Corp. logo
WAYReportable Segment — Amortization
$34.47M+22.6%
Mirum Pharmaceuticals, Inc. logo
MIRMReportable Segment — Amortization expense
$6.69M+13.4%
BellRing Brands logo
BRBRReportable Segment — Intangible Amortization
$4.2M0.0%
MBC
MBCReportable Segment — Amortization of intangibles
$6.4M0.0%

Other financials

Income statement

See full
Revenue$186.7M+11.1%
Gross profit$80.9M+10.4%
Operating income-$18.2M+34.4%
Net income-$17.1M+34.0%
EPS (diluted)-$0.13+35.0%

Balance sheet

See full
Cash & equivalents$146.1M-57.8%
Total debt$66.3M+5.3%
Total equity$828.8M-6.7%
Total assets$1.3B-15.9%

Cash flow

See full
Operating cash flow-$8.1M+67.9%
CapEx$5.0M+11.1%
Free cash flow-$13.1M+56.0%

Valuation

See full
Market cap$1.68B+86.5%
Enterprise value$1.6B+159%
P/S2.3×+0.9×

Profitability

See full
Gross margin43.2%-1.1pp
Operating margin-14.2%+1.1pp
Net margin-13.3%+2.4pp
FCF margin-4.9%—

Returns & leverage

See full
Return on equity-11.6%+6.2pp
Debt / equity0.1×0.0×
Current ratio4.4×+2.4×

Where this comes from

Reported directly by NeoGenomics in its filing.

Tagged under the XBRL concept us-gaap:AdjustmentForAmortization.

The official record: NeoGenomics’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about NeoGenomics's reportable segment — amortization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is NeoGenomics's reportable segment — amortization?
NeoGenomics (NEO) reported reportable segment — amortization of $7.63M in Q1 2026.
How has NeoGenomics's reportable segment — amortization changed year-over-year?
NeoGenomics's reportable segment — amortization decreased by 8.7% year-over-year, from $8.36M to $7.63M.
What is the long-term trend for NeoGenomics's reportable segment — amortization?
Over 3 years (2022 to 2025), NeoGenomics's reportable segment — amortization has grown at a -2.3% compound annual growth rate (CAGR), from $34.06M to $31.75M.
What does reportable segment — amortization mean?
The systematic allocation of the cost of intangible assets over their estimated useful lives within the segment. Monitoring this expense helps investors understand the non-cash impact of past acquisitions and intellectual property investments on segment profitability.